Phase 2 Flu Clinical Trials
42 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 42 trials
Recruiting
Phase 2
BPL-1357 Against H1N1 Influenza Virus Challenge
HumanInfluenza
National Institute of Allergy and Infectious Diseases (NIAID)129 enrolled2 locationsNCT07215858
Recruiting
Phase 2
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Hematopoietic and Lymphoid Cell NeoplasmInfluenza
M.D. Anderson Cancer Center60 enrolled1 locationNCT04712539
Recruiting
Phase 1Phase 2
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Prostate CancerFluorescence ImagingProstate Cancer (Adenocarcinoma)
Antelope Surgical Solutions, Inc10 enrolled2 locationsNCT06906471
Recruiting
Phase 2
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction
Laryngopharyngeal reflux
Medical College of Wisconsin104 enrolled1 locationNCT04383262
Recruiting
Phase 2
Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)
AphasiaAphasia Non FluentAphasia, Acquired+7 more
Teachers College, Columbia University40 enrolled1 locationNCT07036406
Recruiting
Phase 1Phase 2
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
Systemic Inflammatory Response SyndromeSARS CoV-2Respiratory distress syndrome+2 more
PEACHES BIOTECH50 enrolled3 locationsNCT06684379
Recruiting
Phase 2
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
Fluid Retention Caused by Heart Failure
Fujian Shengdi Pharmaceutical Co., Ltd.153 enrolled1 locationNCT07318103
Recruiting
Phase 2
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Primary Progressive AphasiaLogopenic Progressive AphasiaNon-Fluent Primary Progressive Aphasia
Johns Hopkins University180 enrolled3 locationsNCT05386394
Recruiting
Phase 1Phase 2
Clinical Trials of Quadrivalent Influenza Vaccine
Influenza, Human
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.620 enrolled1 locationNCT06824519
Recruiting
Phase 2
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
EIP Pharma Inc20 enrolled7 locationsNCT07033481
Recruiting
Phase 2
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
InfluenzaTransplantation InfectionImmunization; Infection
National Institute of Allergy and Infectious Diseases (NIAID)312 enrolled8 locationsNCT05947071
Recruiting
Phase 2
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
InfluenzaInfluenza, Human
University of Oxford3,000 enrolled4 locationsNCT05648448
Active
Phase 2
A Phase 2, Randomized, Observer-Blind, Dose Finding Trial to Evaluate Safety and Immunogenicity of an Investigational Pandemic Flu Vaccine
Influenza
PPD Australia PTY LTD180 enrolled1 locationACTRN12626000417381
Recruiting
Phase 1Phase 2
Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults
Avian Influenza A Virus
Butantan Institute700 enrolled5 locationsNCT06842173
Recruiting
Phase 2
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety
Anxiety DisordersDepression DisordersHepatobiliary Malignancy+1 more
First Affiliated Hospital of Wenzhou Medical University240 enrolled1 locationNCT07174947
Recruiting
Phase 1Phase 2
Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Influenza
Aramis Biotechnologies Inc.728 enrolled7 locationsNCT07291635
Recruiting
Phase 2
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
COVID-19Inflammatory Bowel DiseaseRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre660 enrolled3 locationsNCT06599658
Recruiting
Phase 2
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Prostate CancerProstate CarcinomaProstate Neoplasm+15 more
Shehzad Basaria, M.D.60 enrolled1 locationNCT06957691
Recruiting
Phase 2
BAL Fluid Biomarkers in Sarcoma
Soft Tissue Sarcoma (STS)Bronchoalveolar Lavage (BAL)Bronchoalveolar Lavage Fluid
University Health Network, Toronto70 enrolled1 locationNCT06815666
Recruiting
Phase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.
InfluenzaAcute Respiratory Viral Infection
Valenta Pharm JSC300 enrolled11 locationsNCT07420985